The pharmaceutical industry is on the cusp of a transformation, driven by cutting-edge technologies like 3D printing. GMP, a leading UK-based contract manufacturer specializing in pharmaceuticals, cosmetics, and healthcare products, is pioneering this shift.
With a platform that combines hardware, software, and formulation solutions, GMP enables customizable, small-batch medicines tailored to individual needs.
What does this mean for the future of personalized medicine?
Here’s our conversation with Giby George, Group CEO, GMP

Bigger Pic: Middle East tensions cast a shadow over aviation sector
08:49

Breakfast Bites: As AI reshapes roles, what skills should fresh grads prioritise?
05:44

Mind Your Business: The hard truth about food insecurity in Singapore
15:38